Search alternatives:
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
decrease toc » decrease of (Expand search), decrease the (Expand search), decrease on (Expand search)
toc decrease » to decrease (Expand search), the decrease (Expand search), or decrease (Expand search)
decrease not » decrease of (Expand search), decrease at (Expand search), decrease akt (Expand search)
not decrease » to decrease (Expand search), not increase (Expand search), and decrease (Expand search)
decrease an » decrease and (Expand search), decrease in (Expand search), decrease at (Expand search)
an altered » and altered (Expand search), are altered (Expand search), is altered (Expand search)
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
decrease toc » decrease of (Expand search), decrease the (Expand search), decrease on (Expand search)
toc decrease » to decrease (Expand search), the decrease (Expand search), or decrease (Expand search)
decrease not » decrease of (Expand search), decrease at (Expand search), decrease akt (Expand search)
not decrease » to decrease (Expand search), not increase (Expand search), and decrease (Expand search)
decrease an » decrease and (Expand search), decrease in (Expand search), decrease at (Expand search)
an altered » and altered (Expand search), are altered (Expand search), is altered (Expand search)
1
“... pilocarpine group. However, they were not altered in the pilocarpine groups pretreated with memantine (a NMDA...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
2
“... pilocarpine group. However, they were not altered in the pilocarpine groups pretreated with memantine (a NMDA...”
Access document
Access document
Article
3
“..., N = 7) decreases significantly (P = 0.016) when compared to normal rats (3.2 ± 0.3 ml/min, N = 6). The AP response...”
Access document
Access document
Article
4
“..., N = 7) decreases significantly (P = 0.016) when compared to normal rats (3.2 ± 0.3 ml/min, N = 6). The AP response...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
5
“... experimental periods. The cardiac morphological and functional parameters were not altered. Although down...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
6
“...-melanin synthesis pathway showed a decreased expression. Other amino acids do not trigger pyomelanin...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
7
“...-melanin synthesis pathway showed a decreased expression. Other amino acids do not trigger pyomelanin...”
Access document
Access document
Article
8
“... injury, its organization is altered by the repair process, compromising the physiological mechanical...”
Access document
Access document
Article
9
“... did not alter the number of NeuN+ neurons in the rat mPFC. However, a very significant decrease...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
10
“... accepted academic practice. No use, distribution or reproduction is permitted which does not comply with...”
Access document
Access document
Article
11
“... DOX-treated rats. We show for the first time that DOX treatment decreases global DNA methylation...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
12
13
“...Embryonic and placental development is highly orchestrated by epigenetic processes. Disruptions...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
14
15
16
“... response if full adaptation is not displayed. However, our current knowledge of several coexisting factors...”
Access document
Access document
Article
17
“... in a linear decrease of muscle yellowness from 3.99 to 3.29. Dietary glycerin altered intramuscular fat fatty...”
Access document
Access document
Article
18
“... in a linear decrease of muscle yellowness from 3.99 to 3.29. Dietary glycerin altered intramuscular fat fatty...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
19
20